Abivax pops 19% on market talk about Eli Lilly takeover interest

Abivax SA

10/12/2025 09:53

** Shares in French biotech company Abivax ABVX.PA up as much as 19% with two traders citing market speculation about  potential takeover interest from Eli Lilly LLY.N

** Abivax and Eli Lilly were not immediately available for comment

** If gains hold, Abivax will add 1.5 billion euros to its market value of 7.8 billion euros ($9.1 billion)

($1 = 0.8592 euros)

 (Reporting by Gianluca Lo Nostro; editing by Danilo Masoni)

 ((gianluca.lonostro@thomsonreuters.com;))